OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2025.15075 OL-30-1-15075 Retraction [Retracted] lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection WuJiansong NiuQiang YuanJie XuXiaodan CaoLiuxia 07 2025 06 05 2025 30 1 329 Copyright: © 2025 Wu et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 20: 235–247, 2020; DOI: 10.3892/ol.2020.11534

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the FISH and immunofluorescence assay data shown in Fig. 4J and L, and certain of the immunohistochemical data in Fig. 5D, were strikingly similar to data that had already appeared in previously published articles written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.